Evercore ISI analyst Vijay Kumar initiated coverage of GE HealthCare with an Outperform rating and $90 price target, which represents 17% upside from current levels. The analyst believes the company’s positive pricing and platforming initiatives could uplift margins by 50-100 basis points annually. The firm says its revenue acceleration thesis rests on GE HealthCare’s pricing and innovation.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on GEHC:
- GE HealthCare stock had a great start, more gains lie ahead, Barron’s says
- General Electric price target raised to $96 at BofA ahead of investor day
- GE HealthCare, Advantus Health in pact to provide HTM services
- GE HealthCare completes recruitment in manganese-based MRI contrast agent study
- GE HealthCare initiated with a Buy at Mizuho